TAIWAN REACHED A 92.7% HEPATITIS C TREATMENT RATE.
More than 7.86 million people have been screened. Diagnosis reached 92.4%, treatment 92.7%, and treatment in key high-risk groups 95%.
Taiwan’s hepatitis C program reports screening more than 7.86 million people, diagnosing 92.4% of identified infections and treating 92.7%. Treatment coverage in key high-risk groups reached 95%.
WHAT HAPPENED
Taiwan expanded public drug coverage in 2017 and removed disease-severity restrictions in 2019, turning curative antiviral therapy into a population-scale program. By 2026, more than 7.86 million people had been screened. Reported diagnosis and treatment rates reached 92.4% and 92.7%, while treatment among key high-risk groups reached 95%.
Health authorities also report declines in liver-cancer incidence and mortality. The figures are substantial progress indicators, but they do not mean transmission has ended; continued screening and follow-up remain necessary.
WHY THIS IS HOPESLOP
Hepatitis C is curable, but only if people are found and treatment is reachable. Taiwan’s program converted that simple truth into public infrastructure: screen widely, remove rationing rules and keep closing the gap between diagnosis and cure.
ORIGINAL SOURCECommercial Times (Taiwan)Read the original report
A DAILY ALLEGATION OF PROGRESS.
One good thing from the internet, every day. Nothing else.